Seer Inc.

AI Score

0

Unlock

2.04
-0.06 (-2.86%)
At close: Mar 03, 2025, 3:59 PM
2.06
0.98%
After-hours: Mar 03, 2025, 04:00 PM EST
No 1D chart data available
Bid 1.99
Market Cap 120.29M
Revenue (ttm) 13.74M
Net Income (ttm) -79.66M
EPS (ttm) -1.3
PE Ratio (ttm) -1.57
Forward PE -1.48
Analyst Hold
Ask 2.19
Volume 378,640
Avg. Volume (20D) 212,834
Open 2.10
Previous Close 2.10
Day's Range 2.04 - 2.14
52-Week Range 1.56 - 2.63
Beta 1.59

About SEER

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover...

Industry Biotechnology
Sector Healthcare
IPO Date Dec 4, 2020
Employees 147
Stock Exchange NASDAQ
Ticker Symbol SEER
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for SEER stock is "Hold." The 12-month stock price forecast is $3, which is an increase of 47.06% from the latest price.

Buy 0.00%
Hold 100.00%
Sell 0.00%
Stock Forecasts

Earnings Surprise

Seer has released their quartely earnings on Feb 27, 2025:
  • Revenue of $4M exceeds estimates by $50K, with -9.87% YoY decline.
  • EPS of -0.37 exceeds estimates by 0.02, with -32.14% YoY decline.
  • Next Earnings Release

    Seer Inc. is scheduled to release its earnings on May 7, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription